On November 8th, Geely Science released its financial report for the third quarter of 2023 on its official WeChat account. The sales volume of products (excluding remdesivir) increased by 5% year-on-year to US $6.4 billion; Remdesivir's sales were $636 million, down 31% year on year. Among them, the sales of BikeEnBingNuo tablets increased by 12% year-on-year, reaching 3.1 billion US dollars; The sales of oncology products increased by 33% year-on-year, reaching $769 million.